Robotic Surgery

Introduction

Robotic surgery has evolved from a speculative concept to a global healthcare standard that transforms how surgeons approach complex procedures across nearly every medical specialty. Intuitive Surgical’s da Vinci system, the most widely deployed surgical robot in the world, has performed over 10 million minimally invasive procedures since its inception, with the installed base exceeding 6,730 systems across 69 countries. The global robotic surgery market was valued at approximately USD 15.2 billion in 2025 and is projected to reach USD 52.1 billion by 2034, growing at a compound annual growth rate of 14.5 percent. Studies comparing robotic-assisted and open surgery for colorectal cancer found that patients undergoing robotic procedures experienced significantly fewer complications at 14.1 percent versus 21.2 percent and shorter hospital stays at 6.7 versus 8.4 days. The convergence of artificial intelligence, haptic feedback, telesurgery, and cloud-connected analytics in platforms like the da Vinci 5 is accelerating this transformation. This article examines the AI-powered evolution of robotic surgery, covering the technology, clinical evidence, risks, ethics, market dynamics, and the future of surgical automation.

Essential Facts About Robotic Surgery

What is robotic surgery?

Robotic surgery uses computer-controlled robotic arms with specialized instruments to assist surgeons in performing minimally invasive procedures. The surgeon operates from a console with 3D visualization while the robot translates hand movements into precise instrument actions inside the patient’s body.

How much does a surgical robot cost?

The da Vinci surgical system requires an initial investment exceeding USD 2 million alongside annual maintenance fees of approximately USD 100,000. Newer competitors are targeting lower price points to expand access beyond large academic medical centers.

Is robotic surgery safer than traditional surgery?

Studies show robotic surgery reduces complications by approximately 25 to 30 percent compared to open surgery, with shorter hospital stays and faster recovery. The conversion rate from robotic to open surgery ranges from 0.8 to 5 percent depending on the procedure.

Key Takeaways

• Over 10 million procedures have been performed using da Vinci surgical systems across 69 countries, with 1.8 million procedures in 2024 alone.
• The da Vinci 5, cleared by the FDA in 2024, introduces force feedback (haptics), AI-powered surgical insights, and over 10,000 times more computing power than its predecessor.
• AI-assisted robotic surgeries demonstrated a 25 percent reduction in operative time and a 30 percent decrease in intraoperative complications compared to manual methods.
• The global robotic surgery market is projected to grow from USD 15.2 billion in 2025 to USD 63.73 billion by 2035 at a 16.54 percent CAGR.

What Robotic Surgery Means for Modern Medicine

Robotic surgery uses computer-controlled robotic arms equipped with specialized instruments and high-definition cameras to assist surgeons in performing minimally invasive procedures with enhanced precision, flexibility, and visualization beyond the limits of human hands alone.

The Evolution from ZEUS to da Vinci 5

The history of robotic surgery stretches back to the mid-1990s, when Computer Motion created two groundbreaking systems that proved machines could meaningfully assist in the operating room. AESOP, introduced in 1994, became the first FDA-approved robotic laparoscopic camera holder, giving surgeons voice-controlled camera positioning during procedures. ZEUS followed in 1998, introducing the master-slave paradigm where a surgeon at a console controlled robotic arms at the patient's bedside. Using ZEUS, surgeons performed the legendary Lindbergh Operation in September 2001, a remote cholecystectomy with the surgeon in New York and the patient in Strasbourg, France, separated by thousands of miles. This transatlantic procedure demonstrated that distance need not limit surgical expertise.

Intuitive Surgical's da Vinci system received FDA clearance for general laparoscopic procedures in 2000, and within two decades it came to dominate the global surgical robotics market. The company's growth trajectory illustrates the accelerating adoption curve: from 60 systems sold in 2002 to over 6,730 installed systems worldwide by late 2021, while revenue climbed from USD 1.41 billion in 2010 to USD 10.1 billion in 2025. The da Vinci platform has undergone four major generational upgrades, each expanding the range of procedures it can support and the precision it delivers. The latest generation, da Vinci 5, received FDA clearance in 2024 and introduced capabilities that represent the most significant leap since the original system. The integration of artificial intelligence into this latest platform marks a new era where surgical robots are not merely tools but intelligent collaborators.

In January 2026, Intuitive obtained FDA clearance for cardiac surgery applications on the da Vinci 5 platform, including mitral valve repair and coronary artery bypass grafting. This expansion into cardiothoracic surgery, one of the most demanding surgical specialties, signals the maturity and reliability of the robotic platform. The same month, Johnson and Johnson submitted a De Novo application for its OTTAVA robotic system with machine-learning collision prediction, introducing a direct competitor to the da Vinci ecosystem after years of development.

How a Surgical Robot Operates

A surgical robot system consists of three primary components: a surgeon console, patient-side robotic arms equipped with instruments, and a high-definition 3D endoscopic camera system. The surgeon sits at the console, which provides an immersive three-dimensional view of the surgical site magnified up to ten times beyond what the naked eye can see. Hand controllers at the console translate the surgeon's movements into corresponding motions of the robotic instruments inside the patient, with built-in tremor filtering that eliminates the natural hand shaking that all humans exhibit. The instruments themselves feature articulating tips with seven degrees of freedom, exceeding the range of motion of the human wrist and enabling precise maneuvers in tight anatomical spaces.

The robotic arms enter the patient's body through small incisions, typically 8 to 12 millimeters in diameter, rather than the large openings required for traditional open surgery. This minimally invasive approach reduces tissue damage, blood loss, infection risk, and postoperative pain. The camera system provides the surgeon with a detailed view that reveals anatomical structures that would be difficult or impossible to see during open procedures. The combination of enhanced visualization, scaled motion, tremor elimination, and articulated instruments creates a surgical environment where precision exceeds what any human hand can achieve unaided. The role of AI in robotics is particularly transformative in this context, where the stakes of every movement are measured in patient outcomes.

AI Integration in Robotic Surgical Systems

The integration of artificial intelligence into robotic surgery is moving the field beyond mere teleoperation toward intelligent surgical assistance. AI algorithms now analyze intraoperative video feeds in real time, identifying anatomical structures, tracking instrument positions, and alerting surgeons to potential hazards. Computer vision systems can distinguish between tissue types, highlight blood vessels that should be preserved, and map the boundaries of tumors with precision that augments the surgeon's own judgment. A 2025 meta-analysis of 25 peer-reviewed studies found that AI-assisted robotic surgeries demonstrated a 25 percent reduction in operative time and a 30 percent decrease in intraoperative complications compared to manual methods.

Machine learning models trained on thousands of recorded procedures enable robotic systems to learn from past surgeries and improve their performance over time. These models identify patterns in surgical technique that correlate with better outcomes, creating a feedback loop where the system becomes more helpful as its data library grows. The da Vinci 5 leverages cloud connectivity and onboard analytics to gather surgical data globally, enabling video replay, digital case analysis, performance metrics, and personalized coaching for surgeons. The distinction between machine learning and deep learning becomes clinically relevant as more sophisticated neural networks process the complex visual and kinematic data generated during robotic procedures.

Surgical precision improved by approximately 40 percent through AI-enhanced targeting accuracy during tumor resections and implant placements, according to the same meta-analysis. Patient recovery times shortened by an average of 15 percent, with lower postoperative pain scores across studied procedures. Surgeon workflow efficiency increased by approximately 20 percent, while healthcare costs decreased by roughly 10 percent compared to conventional approaches. These numbers represent aggregate improvements across multiple specialties and procedure types, with individual results varying based on surgical complexity and institutional experience.

The da Vinci 5 and Force Feedback

The most anticipated feature of the da Vinci 5 is force feedback, also known as haptics. For the first time in the da Vinci product line, surgeons can feel forces at the instrument tips, receiving tactile cues about tissue interaction. Previous da Vinci generations relied entirely on visual feedback, requiring surgeons to judge tissue resistance by watching how tissues deformed under instrument pressure. The addition of haptic feedback provides a critical sensory channel that makes the robotic interface feel more natural and reduces the risk of applying excessive force to delicate structures. Early preclinical data suggest that force feedback can measurably reduce applied force during tissue manipulation.

Beyond haptics, the da Vinci 5 incorporates over 10,000 times more computing power than the Xi generation it replaces. This computational capacity enables real-time AI processing, advanced imaging overlays, and the kind of data-intensive surgical intelligence that previous platforms could not support. Smart operating room integration features allow in-console video review, remote software updates, and streamlined controls designed to improve ergonomics during long procedures. The wave of AI-driven healthcare innovations finds one of its most consequential applications in the operating room, where split-second decisions carried out with sub-millimeter precision determine patient outcomes.

Telesurgery and Remote Surgical Collaboration

Telesurgery represents the next frontier in robotic surgery, enabling surgeons to perform procedures on patients located hundreds or thousands of miles away. At the Society of Robotic Surgery conference in France in July 2025, Intuitive demonstrated transatlantic telesurgery by linking two surgeons 4,000 miles apart using a dual-console da Vinci 5 system. Dr. Doug Stoddard in Peachtree Corners, Georgia, and Dr. Andrea Pakula in Strasbourg shared control of surgical instruments on an advanced tissue model, passing control back and forth remotely. The demonstration built on the legacy of the original Lindbergh Operation performed with the ZEUS system in 2001, but with dramatically improved latency, image quality, and instrument control.

India's indigenous surgical robotic system, SSI Mantra, performed two world-first telesurgeries over a distance of 286 kilometers in January 2025, demonstrating that telesurgery capability is no longer exclusive to Western manufacturers. The combination of 5G networks, cloud computing, and advanced robotic platforms is making real-time remote surgery technically feasible for clinical deployment, though regulatory approval remains pending in most jurisdictions. Intuitive CEO Dave Rosa emphasized that telesurgery is just one component of a broader telecollaboration suite that includes telementoring and teleproctoring, where experienced surgeons guide less experienced colleagues through complex procedures from remote locations. The evolving relationship between robots and humans takes on life-saving dimensions when a surgeon's expertise can be transmitted across continents in real time.

Clinical Outcomes Across Specialties

Robotic surgery has demonstrated measurable clinical benefits across multiple surgical specialties, with the strongest evidence base in urology, gynecology, and general surgery. In urology, robotic-assisted prostatectomy has become the standard of care in many institutions, with studies showing reduced blood loss, shorter hospital stays, and improved continence recovery compared to open approaches. Across 73 hospitals, robotic surgery usage increased from 1.8 percent to 15.1 percent for all general surgery procedures, reflecting growing institutional adoption driven by outcome data and patient demand.

The surgical site infection rate for robotic procedures generally ranges from 0.8 to 2.5 percent, lower than the rates typically observed in open surgery for comparable procedures. The rate of conversion from robotic to open surgery ranges from 0.8 to 5 percent depending on the procedure type and surgeon experience, with more experienced operators achieving lower conversion rates. For colorectal cancer treatment, robotic-assisted patients experienced complication rates of 14.1 percent versus 21.2 percent for open surgery, with shorter hospital stays of 6.7 versus 8.4 days. The integration of AI in medical imaging complements surgical robotics by enabling more precise preoperative planning that guides the robotic procedure.

Training Surgeons for Robotic Platforms

The learning curve for robotic surgery presents both opportunities and challenges for surgical training programs. Surgeons must develop proficiency in console operation, instrument control, camera navigation, and the cognitive shift from direct tissue interaction to mediated robotic manipulation. The da Vinci 5 addresses training through data-driven surgical coaching: the system tracks every movement a surgeon makes, developing algorithms that highlight differences between expert and novice techniques. This performance analytics capability enables personalized training programs where surgeons can identify specific skills requiring improvement through objective data rather than subjective assessment.

Simulation-based training using virtual reality platforms allows surgeons to practice robotic procedures on realistic digital models before operating on patients. These simulators replicate the console interface, instrument response characteristics, and tissue behavior of the actual robotic system, providing a safe environment for building foundational skills. The transition from simulation to supervised clinical practice typically requires 20 to 40 cases under proctorship before a surgeon achieves independent proficiency, though this number varies significantly by specialty and procedure complexity. The combination of simulation training, performance analytics, and telementoring from experienced surgeons creates a comprehensive training ecosystem that can accelerate skill development while maintaining patient safety standards.

Ethical Questions in Automated Surgery

The increasing autonomy of surgical robots raises ethical questions about the appropriate boundary between human judgment and machine decision-making in the operating room. Current systems operate under the surgeon's direct control at all times, but research into automated surgical subtasks, such as AI-controlled suturing and tissue dissection, is advancing rapidly. The prospect of a robot performing routine surgical steps without direct human input creates questions about accountability when complications occur. If an AI-controlled suturing algorithm fails, is the surgeon, the manufacturer, or the hospital responsible for the outcome?

Informed consent presents another ethical dimension. Patients undergoing robotic surgery should understand that their procedure involves a machine controlled by a surgeon rather than the surgeon's hands directly touching their tissues. The level of detail appropriate for informed consent varies by institution and jurisdiction, but transparency about the role of technology in the surgical process is essential for maintaining patient trust. The broader impact of automation in healthcare intersects with surgical robotics at the point where efficiency gains must be balanced against patient autonomy and the right to know how their care is being delivered.

Risks and Limitations of Surgical Robots

Robotic surgery carries risks that are both shared with traditional surgery and unique to the robotic approach. Mechanical failures, while rare, can occur during procedures and may require conversion to open surgery if the robotic system cannot be quickly restored. The complexity of the robotic platform introduces failure modes that do not exist in conventional surgery, including software errors, instrument malfunctions, and communication delays between the console and the robotic arms. Training-related errors account for a significant proportion of robotic surgical complications, particularly during a surgeon's early experience with the platform.

The cost structure of robotic surgery represents a significant limitation for healthcare systems operating under budget constraints. The initial capital investment of USD 2 million or more per system, combined with annual maintenance costs of approximately USD 100,000 and the expense of single-use instruments, creates a financial barrier that many hospitals cannot overcome. These costs are passed through to patients and insurers, raising questions about whether the clinical benefits justify the premium over conventional surgical approaches that achieve adequate outcomes at lower cost. The debate over cost-effectiveness intensifies in resource-limited settings where the same investment could fund multiple conventional operating rooms.

Cost Barriers and Healthcare Equity

The geographic distribution of surgical robots reveals a significant equity gap in global healthcare. North America holds approximately 42 to 59 percent of the global installed base, with the United States alone accounting for the majority of da Vinci systems. Europe follows with roughly 25 percent of installations, while Asia Pacific is the fastest-growing region, driven by expansion in China, Japan, and India. China saw a 64 percent rise in robotic surgery installations between 2022 and 2024, while Japan achieved 70 percent utilization rates in oncology and urology. India's procedure growth of 53 percent reflects increasing demand coupled with the introduction of indigenous platforms like SSI Mantra that reduce dependency on imported systems.

The high cost of robotic systems concentrates advanced surgical capabilities in large urban academic medical centers, leaving rural and community hospitals without access to the technology. Patients in underserved areas must travel significant distances to reach facilities equipped with surgical robots, creating delays in care and exacerbating existing health disparities. Telesurgery and telementoring offer potential solutions by extending robotic surgical expertise to remote locations, but these capabilities remain investigational and are not yet approved for routine clinical use. The role of automation in healthcare processes includes reducing administrative and procedural costs that contribute to the overall expense of robotic surgical programs.

Competing Platforms and Market Dynamics

While Intuitive Surgical commands roughly 70 to 80 percent of the global surgical robotics market, competition is intensifying as patents expire and new players enter the field. Medtronic's Hugo RAS (robotic-assisted surgery) system received multiple global market-entrance approvals in 2022, targeting general surgery and urology with a modular, cost-competitive design. Johnson and Johnson's OTTAVA system incorporates machine-learning collision prediction and aims to challenge the da Vinci ecosystem with differentiated AI capabilities. Stryker dominates robotic orthopedics with the Mako system, while Zimmer Biomet competes with ROSA for knee and spine surgery applications.

CMR Surgical's Versius system has gained traction in Europe and Asia Pacific with a smaller, more portable design that fits into existing operating rooms without the infrastructure modifications required by larger systems. The Versius approach targets a different market segment: hospitals that want robotic capabilities but cannot justify the space and cost requirements of a full da Vinci installation. Intuitive's expiring patents are enabling new competitors to enter the field, which analysts expect will drive down costs and expand global access to robotic surgery over the coming decade. The explosive growth in robotics extends well beyond surgery, but the surgical segment commands some of the highest per-unit values in the entire robotics market.

Global Market Growth and Regional Adoption

The global robotic surgery market is growing at a rate that reflects both expanding clinical applications and increasing institutional adoption. Market estimates vary across research firms, but the consensus points to strong double-digit growth through at least 2034. Persistence Market Research valued the market at USD 12.93 billion in 2025 with a projection to USD 41.04 billion by 2032 at a 17.4 percent CAGR. Intel Market Research estimated USD 15.2 billion in 2025 growing to USD 52.1 billion by 2034 at a 14.5 percent CAGR. Towards Healthcare projected growth from USD 13.79 billion in 2025 to USD 63.73 billion by 2035 at a 16.54 percent CAGR. The US market alone was valued at USD 4.46 billion in 2025 and is expected to exceed USD 16.68 billion by 2034.

North America leads with 42.71 percent market share in 2025, driven by favorable reimbursement policies, high surgeon adoption rates, and a concentration of early-adopter academic medical centers. Asia Pacific is the fastest-growing region, with a projected CAGR of approximately 9.88 percent, fueled by investments in healthcare infrastructure, increasing chronic disease burden, and government initiatives to modernize surgical capabilities. The da Vinci system contributed USD 2.41 billion in revenue in Q4 2024 alone, representing a 25 percent increase compared to the previous period. Installations rose from 1,370 in 2023 to 1,526 in 2024 in the United States, while 75 percent of tertiary care hospitals now routinely use robotic surgery.

The Future of Robotic Surgery

The future of robotic surgery is being shaped by three converging forces: increasing AI autonomy, expanding surgical applications, and cost reduction through competition and scale. The next generation of surgical robots will likely perform certain routine subtasks autonomously while the surgeon retains supervisory control and decision-making authority. Automated suturing, tissue retraction, and camera positioning are among the first candidates for autonomous execution, as these tasks follow predictable patterns that can be reliably performed by AI systems trained on thousands of recorded procedures. The goal, as expressed by multiple industry leaders, is not to replace surgeons but to make them superhuman.

Digital twin technology is emerging as a powerful preoperative planning tool, where AI creates a patient-specific virtual model of the surgical anatomy from imaging data. Surgeons can practice the planned procedure on the digital twin before performing it on the actual patient, identifying potential challenges and optimizing their approach. Cloud-connected robotic platforms will enable continuous learning from surgical data generated across thousands of hospitals worldwide, creating a global knowledge base that improves outcomes for every patient. The impact of AI across specialized medical fields like ophthalmology provides a roadmap for how surgical robotics will evolve in other disciplines.

Cost reduction will accelerate as Intuitive's patent protections expire and competitors scale production of alternative platforms. The entry of players like Medtronic, Johnson and Johnson, and CMR Surgical is already creating pricing pressure that benefits healthcare systems. Analysts project that smaller, more affordable robotic systems will reach community hospitals and ambulatory surgery centers within the next five to seven years, dramatically expanding the patient population that can access robotic surgical care. The combination of lower costs, AI-driven efficiency gains, and proven clinical outcomes positions robotic surgery to become the standard of care across the majority of surgical specialties within the next decade.

Key Insights on Robotic Surgery

• Over 10 million procedures performed using da Vinci systems across 69 countries, with more than 6,730 systems installed worldwide.
• AI-assisted robotic surgeries demonstrated a 25 percent reduction in operative time and 30 percent decrease in complications compared to manual methods across 25 peer-reviewed studies.
• Robotic colorectal surgery patients experienced 14.1 percent complication rates versus 21.2 percent for open surgery, with hospital stays of 6.7 versus 8.4 days.
• The da Vinci 5 features over 10,000 times more computing power than the Xi and introduces force feedback for the first time in the da Vinci product line.
• Intuitive Surgical's revenue reached USD 10.1 billion in 2025, commanding 70 to 80 percent of the global surgical robotics market.
• The global robotic surgery market is projected to grow from USD 13.79 billion in 2025 to USD 63.73 billion by 2035 at a 16.54 percent CAGR.
• Intuitive demonstrated 4,000-mile transatlantic telesurgery using a dual-console da Vinci 5 at the Society of Robotic Surgery conference in July 2025.

The evidence base for robotic surgery has matured from early case series to large multi-center comparative studies that consistently demonstrate measurable advantages over conventional approaches. The clinical benefits of reduced complications, shorter hospital stays, and faster recovery translate into economic advantages despite the higher upfront cost of robotic platforms. The technology's expansion from urology and gynecology into cardiothoracic, orthopedic, and neurological surgery reflects growing confidence in robotic precision across anatomical contexts. Telesurgery demonstrations have moved from proof-of-concept to near-clinical-readiness, potentially solving the geographic mismatch between surgical expertise and patient need. The investment landscape confirms that the market sees robotic surgery as a durable growth sector, with multiple large-cap medical device companies committing billions to compete with Intuitive's market dominance.

Dimension	Robotic Surgery	Open Surgery
Incision Size	8-12mm ports	15-30cm incisions
Complication Rate	14.1% (colorectal)	21.2% (colorectal)
Hospital Stay	6.7 days average	8.4 days average
Surgical Precision	40% improvement with AI	Dependent on surgeon skill
Operative Time	25% reduction with AI	Standard baseline
Equipment Cost	USD 2M+ per system	Standard OR equipment
Surgeon Fatigue	Reduced via ergonomic console	Physically demanding
Remote Capability	Telesurgery possible (investigational)	Surgeon must be present

Robotic Surgery Systems Transforming Patient Care

Da Vinci System in Prostatectomy

The da Vinci system has become the standard of care for radical prostatectomy in the United States and many European countries. The procedure requires precise nerve-sparing technique to preserve urinary continence and sexual function, capabilities that benefit directly from the robot's magnified 3D visualization and articulated instruments. Large comparative studies have shown that robotic prostatectomy results in lower blood loss, shorter hospital stays, and faster return to continence compared to open surgery. The measurable impact includes complication rates below 10 percent in experienced centers and average hospital stays of one to two days versus three to five days for open procedures. The limitation is the learning curve: surgeons require 50 to 100 cases to achieve proficiency comparable to experienced open surgeons, and outcomes during the learning phase may not match those of expert practitioners. Urology remains the most common specialty for robotic surgery globally.

Versius System Expanding Access in Europe

CMR Surgical's Versius system has been deployed across hospitals in Europe, Asia, and Australia, targeting institutions that want robotic capabilities but lack the infrastructure or budget for a full da Vinci installation. The system's modular design allows individual robotic arms to be positioned around the patient independently, fitting into existing operating rooms without major renovations. Versius has been used across multiple specialties including gynecology, general surgery, and urology. The measurable impact includes expanded access to robotic surgery in hospitals that would otherwise offer only conventional laparoscopic or open approaches. The limitation is the system's relative immaturity compared to the da Vinci ecosystem: fewer published outcome studies, a smaller user community, and limited long-term safety data compared to the extensively studied da Vinci platform.

Mako System Revolutionizing Joint Replacement

Stryker's Mako system has transformed orthopedic surgery by combining robotic precision with preoperative CT-based planning for knee and hip replacement procedures. The system creates a patient-specific three-dimensional model of the joint before surgery, allowing the surgeon to plan bone cuts and implant positioning with millimeter accuracy. During the procedure, the robotic arm constrains the surgeon's movements to the pre-planned cutting boundaries, preventing accidental removal of healthy bone. The measurable impact includes improved implant alignment, reduced revision surgery rates, and higher patient satisfaction scores compared to conventional joint replacement. The limitation is the additional preoperative imaging required and the extended operating room setup time, which adds cost and reduces surgical throughput compared to conventional techniques.

Landmark Deployments in Surgical Robotics

Case Study: KIMS Hospitals Expanding Robotic Access in India

In October 2024, Krishna Institute of Medical Sciences (KIMS) hospitals partnered with Intuitive to launch 25 robotic surgery programs featuring da Vinci systems across Maharashtra, Karnataka, Andhra Pradesh, and Telangana. The problem was that robotic surgery in India had been concentrated in a handful of major metropolitan hospitals, leaving patients in Tier 2 and Tier 3 cities without access to minimally invasive robotic procedures. The solution involved establishing robotic programs across KIMS's network of hospitals spanning multiple states, with dedicated training programs for local surgical teams. The measurable impact was a 53 percent growth in robotic procedures across India, with KIMS hospitals contributing significantly to this expansion. The limitation was sustainability: maintaining robotic programs in smaller facilities requires ongoing investment in maintenance, instrument supply chains, and surgeon training that challenges the financial models of hospitals in price-sensitive markets.

Case Study: Southmead Hospital and Gynecological Robotic Surgery

In May 2025, Southmead Hospital became the first facility in the South West of England to install a gynecological surgery robot. The da Vinci Xi system is used to perform hysterectomies, excision of endometriosis, and other gynecological procedures. The problem was that patients in the South West requiring complex gynecological surgery had limited access to minimally invasive robotic options, often requiring travel to London or other major cities. The solution brought robotic capability to a regional hospital that serves a large geographic area. The system is estimated to benefit 144 gynecological patients annually, reducing their recovery times and need for extended hospital stays. The limitation is capacity: with a single system serving the entire region, waiting times for robotic procedures may exceed those at larger centers with multiple robotic platforms.

Case Study: SSI Mantra Telesurgery in India

India's indigenous SSI Mantra surgical robotic system performed two world-first telesurgeries over a distance of 286 kilometers in January 2025. The problem was that rural areas in India face severe shortages of specialist surgeons, particularly for complex procedures that require robotic precision. The SSI Mantra team demonstrated that a surgeon in one city could operate on a patient in another using 5G connectivity and the domestically manufactured robotic platform. The measurable impact was proof that telesurgery using non-Western robotic platforms is technically achievable at clinically meaningful distances. The limitation was that the procedures were performed under controlled research conditions rather than routine clinical practice, and regulatory approval for commercial telesurgery has not yet been granted in India. The real-world application of AI in healthcare requires this kind of pioneering work to establish safety and efficacy before broader clinical adoption.

Frequently Asked Questions on Robotic Surgery